Literature DB >> 11192523

Ventricular energetics in Fontan circulation: evaluation with a theoretical model.

M Nogaki1, H Senzaki, S Masutani, J Kobayashi, T Kobayashi, N Sasaki, H Asano, S Kyo, Y Yokote.   

Abstract

BACKGROUND: Both pulmonary and systemic circulation must be maintained by a single pump in Fontan circulation. This unique property of Fontan circulation may be related to decreased exercise tolerance or increased instantaneous postoperative mortality rate, often observed in patients with this circulation. To better understand Fontan physiology, the present study theoretically investigated cardiac performance of Fontan circulation by using ventricular-vascular coupling framework analysis.
METHODS: End-systolic volume elastance (Ees), as a chamber contractile property, and effective arterial elastance (Ea), a lumped measure of ventricular afterload, were estimated both in normal left ventricular systemic circulation and in Fontan circulation.
RESULTS: End-systolic volume elastance was decreased and Ea was increased in Fontan circulation. Both ventricular external stroke work (SW) and mechanical efficiency (EFF) under Fontan circulation were lower compared with those under normal circulation. Furthermore, the Ees-Ea relationship in Fontan circulation predicted limited cardiac reserve in terms of SW and EFF. Such cardiac performance in Fontan circulation stemmed from increased impedance due to the additional connection of the pulmonary vascular bed to the systemic vasculature and from the lack of a compensatory increase in contractility for increased afterload.
CONCLUSIONS: Thus, it was inferred that Fontan circulation had intrinsic disadvantages and this may explain, in part, abnormal functional status and decline in survival following this procedure.

Entities:  

Mesh:

Year:  2000        PMID: 11192523     DOI: 10.1046/j.1442-200x.2000.01316.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  7 in total

1.  Heart Failure in Adults who had the Fontan Procedure: Natural History, Evaluation, and Management.

Authors:  Ari Cedars; Susan Joseph; Philip Ludbrook
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 2.  Modeling the Fontan circulation: where we are and where we need to go.

Authors:  C G DeGroff
Journal:  Pediatr Cardiol       Date:  2007-10-05       Impact factor: 1.655

3.  The total cavopulmonary connection resistance: a significant impact on single ventricle hemodynamics at rest and exercise.

Authors:  Kartik S Sundareswaran; Kerem Pekkan; Lakshmi P Dasi; Kevin Whitehead; Shiva Sharma; Kirk R Kanter; Mark A Fogel; Ajit P Yoganathan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-17       Impact factor: 4.733

4.  Sildenafil and ventriculo-arterial coupling in Fontan-palliated patients: a noninvasive echocardiographic assessment.

Authors:  Reza Shabanian; Leila Shahbaznejad; Anahita Razaghian; Abdolrazagh Kiani; Mitra Rahimzadeh; Soroush Seifirad; Armen Kocharian; Jami Shakibi Gilani; Mohammad Ali Navabi
Journal:  Pediatr Cardiol       Date:  2012-08-05       Impact factor: 1.655

5.  Effect of Inhaled Nitric Oxide on Blood Flow Dynamics in Patients After the Fontan Procedure Using Cardiovascular Magnetic Resonance Flow Measurements.

Authors:  Heiner Latus; Bettina Gerstner; Gunter Kerst; Axel Moysich; Kerstin Gummel; Christian Apitz; Juergen Bauer; Dietmar Schranz
Journal:  Pediatr Cardiol       Date:  2015-11-07       Impact factor: 1.655

6.  Induction of aggressive arterial and venous dilation therapy in addition to pulmonary dilation therapy (super-Fontan strategy) improves Fontan circulation both at rest and during treadmill exercise.

Authors:  Shoichi Ishikawa; Shun Matsumura; Akiko Yana; Clara Kurishima; Yoichi Iwamoto; Hirotaka Ishido; Satoshi Masutani; Ryo Nakagawa; Hideaki Senzaki
Journal:  JTCVS Open       Date:  2022-07-16

7.  Ventricular-Arterial Function and Coupling in the Adult Fontan Circulation.

Authors:  Hirofumi Saiki; Benjamin W Eidem; Tomohito Ohtani; Martha A Grogan; Margaret M Redfield
Journal:  J Am Heart Assoc       Date:  2016-09-23       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.